Viking Therapeutics, Inc. VKTX
27.97 USD +1.88 (+7.21%)
At closeNov 4, 2026, 7:56 PM EST
28.04 +0.07 +0.24%
After hours · Nov 4, 7:56 PM ET
26.09 Day range 28.00
23.82 52-week range 43.15
- YTD
- -20.49%
- 1 year
- -19.23%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 95.32 +240.8% upside
Now 27.97
- Target (low)
- 34.00
- Target (mean)
- 95.32
- Target (high)
- 125.00
Ratings (0m) 21 19 buy · 2 hold · 0 sell
- Strong buy5
- Buy14
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 20
- 2 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.35 | -1.63 – -0.90 | -1.38 | +2.4% | 0 | 0.0% | 17 |
| Next quarter | -1.36 | -1.71 – -1.12 | -1.37 | +1.0% | 0 | 0.0% | 7 |
| Current year | -5.31 | -5.66 – -4.58 | -3.19 | -66.5% | 0 | 0.0% | 17 |
| Next year | -5.13 | -7.29 – -3.40 | -5.31 | +3.5% | 0 | 0.0% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 20, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 15, 2026 | UBS | Initiated | — | Buy |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 23, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 28, 2026 | Lake Street | Initiated | — | Buy |
| May 1, 2026 | BTIG | Reiterated | Buy | Buy |
| Apr 30, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 12, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 29, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Oct 24, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 23, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 29, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 22, 2025 | BTIG | Reiterated | Buy | Buy |
| Aug 19, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 24, 2025 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Jul 24, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Jun 25, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 28, 2025 | Cantor Fitzgerald | Initiated | — | Overweight |
| Apr 28, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Apr 24, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 17, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 8, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Mar 26, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 11, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 13, 2025 | Scotiabank | Initiated | — | Sector Outperform |